HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) An addition or correction has been published Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Becker, J. A. J. Articles by Pessi, A. Search for Related Content PubMed PubMed Citation Articles by Becker, J. A. J. Articles by Pessi, A. Social Bookmarking                      What's this?

J Biol Chem, Vol. 274, Issue 39, 27513-27522, September 24, 1999

Ligands for -Opioid and ORL1 Receptors Identified from a Conformationally Constrained Peptide Combinatorial Library

Jérôme A. J. Becker, Andrew Wallace^§, Aaron Garzon^§, Paolo Ingallinella^§, Elisabetta Bianchi^§, Riccardo Cortese^§, Frédéric Simonin, Brigitte L. Kieffer, and Antonello Pessi^§

From the  Ecole Supérieure de Biotechnologie de Strasbourg, 67400 Illkirch, France and ^§ IRBM P. Angeletti, 00040 Rome, Italy

We have screened a synthetic peptide combinatorial library composed of 2 × 10⁷ -turn-constrained peptides in binding assays on four structurally related receptors, the human opioid receptors µ, , and  and the opioid receptor-like ORL1. Sixty-six individual peptides were synthesized from the primary screening and tested in the four receptor binding assays. Three peptides composed essentially of unnatural amino acids were found to show high affinity for human -opioid receptor. Investigation of their activity in agonist-promoted stimulation of [³⁵S]guanosine 5'-3-O-(thio)triphosphate binding assay revealed that we have identified the first inverse agonist as well as peptidic antagonists for -receptors. To fine-tune the potency and selectivity of these -peptides we replaced their turn-forming template by other turn mimetic molecules. This "turn-scan" process allowed the discovery of compounds with modified selectivity and activity profiles. One peptide displayed comparable affinity and partial agonist activity toward all four receptors. Interestingly, another peptide showed selectivity for the ORL1 receptor and displayed antagonist activity at ORL1 and agonist activity at opioid receptors. In conclusion, we have identified peptides that represent an entirely new class of ligands for opioid and ORL1 receptors and exhibit novel pharmacological activity. This study demonstrates that conformationally constrained peptide combinatorial libraries are a rich source of ligands that are more suitable for the design of nonpeptidal drugs.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				S. Sirohi, P. Kumar, and B. C. Yoburn {micro}-Opioid Receptor Up-Regulation and Functional Supersensitivity Are Independent of Antagonist Efficacy J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 701 - 707. [Abstract] [Full Text] [PDF]

				D. Wang, X. Sun, and W. Sadee Different Effects of Opioid Antagonists on {micro}-, {delta}-, and {kappa}-Opioid Receptors with and without Agonist Pretreatment J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 544 - 552. [Abstract] [Full Text] [PDF]

				F. Simonin, M. Schmitt, J.-P. Laulin, E. Laboureyras, J. H. Jhamandas, D. MacTavish, A. Matifas, C. Mollereau, P. Laurent, M. Parmentier, et al. RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia PNAS, January 10, 2006; 103(2): 466 - 471. [Abstract] [Full Text] [PDF]

				G. Carra, A. Rizzi, R. Guerrini, T. A. Barnes, J. McDonald, C. P. Hebbes, F. Mela, V. A. Kenigs, G. Marzola, D. Rizzi, et al. [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a Highly Potent and Selective Agonist of the Nociceptin/Orphanin FQ Receptor J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1114 - 1123. [Abstract] [Full Text] [PDF]

				M. Corbani, C. Gonindard, and J.-C. Meunier Ligand-Regulated Internalization of the Opioid Receptor-Like 1: A Confocal Study Endocrinology, June 1, 2004; 145(6): 2876 - 2885. [Abstract] [Full Text] [PDF]

				D. Ott, R. Frischknecht, and A. Pluckthun Construction and characterization of a kappa opioid receptor devoid of all free cysteines Protein Eng. Des. Sel., January 1, 2004; 17(1): 37 - 48. [Abstract] [Full Text] [PDF]

				D. Rizzi, A. Rizzi, R. Bigoni, V. Camarda, G. Marzola, R. Guerrini, C. De Risi, D. Regoli, and G. Calo' [Arg14,Lys15]Nociceptin, a Highly Potent Agonist of the Nociceptin/Orphanin FQ Receptor: in Vitro and in Vivo Studies J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 57 - 63. [Abstract] [Full Text] [PDF]

				C. M. Topham, L. Mouledous, and J.-C. Meunier On the spatial disposition of the fifth transmembrane helix and the structural integrity of the transmembrane binding site in the opioid and ORL1 G protein-coupled receptor family Protein Eng. Des. Sel., July 1, 2000; 13(7): 477 - 490. [Abstract] [Full Text] [PDF]

				L. Mouledous, C. M. Topham, H. Mazarguil, and J.-C. Meunier Direct Identification of a Peptide Binding Region in the Opioid Receptor-like 1 Receptor by Photoaffinity Labeling with [Bpa10,Tyr14]Nociceptin J. Biol. Chem., September 15, 2000; 275(38): 29268 - 29274. [Abstract] [Full Text] [PDF]